{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:20:12Z","timestamp":1792009212210,"version":"4.4.0"},"reference-count":142,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Research Project of Henan province","award":["232102310389"],"award-info":[{"award-number":["232102310389"]}]},{"name":"Science and Technology Research Project of Henan province","award":["23A150007"],"award-info":[{"award-number":["23A150007"]}]},{"name":"Science and Technology Research Project of Henan province","award":["24A150035"],"award-info":[{"award-number":["24A150035"]}]},{"name":"Science and Technology Research Project of Henan province","award":["22HASTIT050"],"award-info":[{"award-number":["22HASTIT050"]}]},{"name":"Science and Technology Research Project of Henan province","award":["24HASTIT070"],"award-info":[{"award-number":["24HASTIT070"]}]},{"name":"Science and Technology Research Project of Henan province","award":["232300421046"],"award-info":[{"award-number":["232300421046"]}]},{"name":"Science and Technology Research Project of Henan province","award":["21603180"],"award-info":[{"award-number":["21603180"]}]},{"name":"Science and Technology Research Project of Henan province","award":["82273816"],"award-info":[{"award-number":["82273816"]}]},{"name":"Science and Technology Research Project of Henan province","award":["22303075"],"award-info":[{"award-number":["22303075"]}]},{"name":"Science and Technology Research Project of Henan province","award":["22303076"],"award-info":[{"award-number":["22303076"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["232102310389"],"award-info":[{"award-number":["232102310389"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["23A150007"],"award-info":[{"award-number":["23A150007"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["24A150035"],"award-info":[{"award-number":["24A150035"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["22HASTIT050"],"award-info":[{"award-number":["22HASTIT050"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["24HASTIT070"],"award-info":[{"award-number":["24HASTIT070"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["232300421046"],"award-info":[{"award-number":["232300421046"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["21603180"],"award-info":[{"award-number":["21603180"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["82273816"],"award-info":[{"award-number":["82273816"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["22303075"],"award-info":[{"award-number":["22303075"]}]},{"name":"Key Scientific Research Project of Higher Education Institutions in Henan Province","award":["22303076"],"award-info":[{"award-number":["22303076"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["232102310389"],"award-info":[{"award-number":["232102310389"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["23A150007"],"award-info":[{"award-number":["23A150007"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["24A150035"],"award-info":[{"award-number":["24A150035"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["22HASTIT050"],"award-info":[{"award-number":["22HASTIT050"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["24HASTIT070"],"award-info":[{"award-number":["24HASTIT070"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["232300421046"],"award-info":[{"award-number":["232300421046"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["21603180"],"award-info":[{"award-number":["21603180"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["82273816"],"award-info":[{"award-number":["82273816"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["22303075"],"award-info":[{"award-number":["22303075"]}]},{"name":"Scientific and technological innovation talents in Colleges and universities in Henan Province","award":["22303076"],"award-info":[{"award-number":["22303076"]}]},{"name":"Natural Science Foundation of Henan","award":["232102310389"],"award-info":[{"award-number":["232102310389"]}]},{"name":"Natural Science Foundation of Henan","award":["23A150007"],"award-info":[{"award-number":["23A150007"]}]},{"name":"Natural Science Foundation of Henan","award":["24A150035"],"award-info":[{"award-number":["24A150035"]}]},{"name":"Natural Science Foundation of Henan","award":["22HASTIT050"],"award-info":[{"award-number":["22HASTIT050"]}]},{"name":"Natural Science Foundation of Henan","award":["24HASTIT070"],"award-info":[{"award-number":["24HASTIT070"]}]},{"name":"Natural Science Foundation of Henan","award":["232300421046"],"award-info":[{"award-number":["232300421046"]}]},{"name":"Natural Science Foundation of Henan","award":["21603180"],"award-info":[{"award-number":["21603180"]}]},{"name":"Natural Science Foundation of Henan","award":["82273816"],"award-info":[{"award-number":["82273816"]}]},{"name":"Natural Science Foundation of Henan","award":["22303075"],"award-info":[{"award-number":["22303075"]}]},{"name":"Natural Science Foundation of Henan","award":["22303076"],"award-info":[{"award-number":["22303076"]}]},{"name":"National Natural Science Foundation of China","award":["232102310389"],"award-info":[{"award-number":["232102310389"]}]},{"name":"National Natural Science Foundation of China","award":["23A150007"],"award-info":[{"award-number":["23A150007"]}]},{"name":"National Natural Science Foundation of China","award":["24A150035"],"award-info":[{"award-number":["24A150035"]}]},{"name":"National Natural Science Foundation of China","award":["22HASTIT050"],"award-info":[{"award-number":["22HASTIT050"]}]},{"name":"National Natural Science Foundation of China","award":["24HASTIT070"],"award-info":[{"award-number":["24HASTIT070"]}]},{"name":"National Natural Science Foundation of China","award":["232300421046"],"award-info":[{"award-number":["232300421046"]}]},{"name":"National Natural Science Foundation of China","award":["21603180"],"award-info":[{"award-number":["21603180"]}]},{"name":"National Natural Science Foundation of China","award":["82273816"],"award-info":[{"award-number":["82273816"]}]},{"name":"National Natural Science Foundation of China","award":["22303075"],"award-info":[{"award-number":["22303075"]}]},{"name":"National Natural Science Foundation of China","award":["22303076"],"award-info":[{"award-number":["22303076"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Lysine-specific demethylase 1 (LSD1\/KDM1A) has emerged as a promising therapeutic target for treating various cancers (such as breast cancer, liver cancer, etc.) and other diseases (blood diseases, cardiovascular diseases, etc.), owing to its observed overexpression, thereby presenting significant opportunities in drug development. Since its discovery in 2004, extensive research has been conducted on LSD1 inhibitors, with notable contributions from computational approaches. This review systematically summarizes LSD1 inhibitors investigated through computer-aided drug design (CADD) technologies since 2010, showcasing a diverse range of chemical scaffolds, including phenelzine derivatives, tranylcypromine (abbreviated as TCP or 2-PCPA) derivatives, nitrogen-containing heterocyclic (pyridine, pyrimidine, azole, thieno[3,2-b]pyrrole, indole, quinoline and benzoxazole) derivatives, natural products (including sanguinarine, phenolic compounds and resveratrol derivatives, flavonoids and other natural products) and others (including thiourea compounds, Fenoldopam and Raloxifene, (4-cyanophenyl)glycine derivatives, propargylamine and benzohydrazide derivatives and inhibitors discovered through AI techniques). Computational techniques, such as virtual screening, molecular docking and 3D-QSAR models, have played a pivotal role in elucidating the interactions between these inhibitors and LSD1. Moreover, the integration of cutting-edge technologies such as artificial intelligence holds promise in facilitating the discovery of novel LSD1 inhibitors. The comprehensive insights presented in this review aim to provide valuable information for advancing further research on LSD1 inhibitors.<\/jats:p>","DOI":"10.3390\/molecules29020550","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:01:13Z","timestamp":1705924873000},"page":"550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9531-0375","authenticated-orcid":false,"given":"Di","family":"Han","sequence":"first","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2131-6728","authenticated-orcid":false,"given":"Jiarui","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8841-1685","authenticated-orcid":false,"given":"Baoyi","family":"Fan","sequence":"additional","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Xue","sequence":"additional","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taigang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoli","family":"Cui","sequence":"additional","affiliation":[{"name":"School of Forensic, Xinxiang Medical University, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-8933","authenticated-orcid":false,"given":"Qinghe","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Duan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-7790","authenticated-orcid":false,"given":"Yongtao","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China"},{"name":"Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China"},{"name":"Xinxiang Key Laboratory of Biomedical Information Research, Xinxiang 453003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nchembio.111","article-title":"Chemical probes for histone-modifying enzymes","volume":"4","author":"Cole","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13048-019-0536-y","article-title":"Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines","volume":"12","author":"Losi","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1039\/C4MD00031E","article-title":"Synthesis and biological evaluation of coumarin\u20131,2,3-triazole\u2013dithiocarbamate hybrids as potent LSD1 inhibitors","volume":"5","author":"Ye","year":"2014","journal-title":"MedChemComm"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.bmcl.2008.01.003","article-title":"Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B","volume":"18","author":"Gooden","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1111\/j.1742-4658.2009.07142.x","article-title":"New roles of flavoproteins in molecular cell biology: Histone demethylase LSD1 and chromatin","volume":"276","author":"Forneris","year":"2009","journal-title":"FEBS J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/bi101776t","article-title":"Thermodynamic characterization of the binding interaction between the histone demethylase LSD1\/KDM1 and CoREST","volume":"50","author":"Hwang","year":"2011","journal-title":"Biochemistry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.celrep.2019.07.058","article-title":"LSD1 inhibition promotes epithelial differentiation through derepression of fate-determining transcription factors","volume":"28","author":"Egolf","year":"2019","journal-title":"Cell Rep."},{"key":"ref_10","first-page":"652","article-title":"LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells","volume":"13","author":"Adamo","year":"2011","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ccr.2012.03.027","article-title":"Breaking the LSD1\/KDM1A addiction: Therapeutic targeting of the epigenetic modifier in AML","volume":"21","author":"Lokken","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2143","article-title":"Regulation of histone methylation by demethylimination and demethylation","volume":"8","author":"Klose","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.12688\/f1000research.12169.1","article-title":"LSD1, a double-edged sword, confers dynamic chromatin regulation but commonly promotes aberrant cell growth","volume":"6","author":"Kozub","year":"2017","journal-title":"F1000Research"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tibs.2008.01.003","article-title":"LSD1: Oxidative chemistry for multifaceted functions in chromatin regulation","volume":"33","author":"Forneris","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature06092","article-title":"p53 is regulated by the lysine demethylase LSD1","volume":"449","author":"Huang","year":"2007","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng.268","article-title":"The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation","volume":"41","author":"Wang","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"21499","DOI":"10.1073\/pnas.1016147107","article-title":"Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molcel.2010.06.006","article-title":"Lysine methylation regulates E2F1-induced cell death","volume":"39","author":"Kontaki","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/0008-5472.CAN-10-2446","article-title":"Demethylation of RB Regulator MYPT1 by Histone Demethylase LSD1 Promotes Cell Cycle Progression in Cancer CellsDemethylation of MYPT1 in Cancer Cells","volume":"71","author":"Cho","year":"2011","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1038\/oncsis.2014.34","article-title":"LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6","volume":"3","author":"Ketscher","year":"2014","journal-title":"Oncogenesis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/carcin\/bgp324","article-title":"Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology","volume":"31","author":"Lim","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/0008-5472.CAN-17-1236","article-title":"LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem\u2013like CellsLSD1 Regulates Liver CSC Self-Renewal via Notch3 Signaling","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4251\/wjgo.v11.i8.622","article-title":"shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C\/PI3K\/AKT signaling pathway","volume":"11","author":"Pan","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1016\/j.celrep.2018.03.012","article-title":"Enhancer activation by pharmacologic displacement of LSD1 from GFI1 induces differentiation in acute myeloid leukemia","volume":"22","author":"Spencer","year":"2018","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00633","DOI":"10.7554\/eLife.00633","article-title":"Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation","volume":"2","author":"Kerenyi","year":"2013","journal-title":"eLife"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"H1862","DOI":"10.1152\/ajpheart.00513.2011","article-title":"Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension","volume":"301","author":"Pojoga","year":"2011","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/med.21334","article-title":"Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: Clinical significance and progress to date","volume":"35","author":"Mould","year":"2015","journal-title":"Med. Res. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/14728222.2020.1762175","article-title":"LSD1: A viable therapeutic target in cutaneous squamous cell carcinoma?","volume":"24","author":"Egolf","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"627375","DOI":"10.1155\/2013\/627375","article-title":"New perspectives on how to discover drugs from herbal medicines: CAM\u2019s outstanding contribution to modern therapeutics","volume":"2013","author":"Pan","year":"2013","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: The pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd1382","article-title":"Key factors in the rising cost of new drug discovery and development","volume":"3","author":"Dickson","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/138620712799361825","article-title":"Computer-aided drug design: Lead discovery and optimization","volume":"15","author":"Xiang","year":"2012","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_33","first-page":"740","article-title":"Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders","volume":"16","author":"Baig","year":"2018","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1080\/07391102.2020.1784790","article-title":"Effect of novel leukemia mutations (K75E & E222K) on interferon regulatory factor 1 and its interaction with DNA: Insights from molecular dynamics simulations and docking studies","volume":"39","author":"Kamaraj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tips.2012.03.012","article-title":"Discovery of boceprevir, a direct-acting NS3\/4A protease inhibitor for treatment of chronic hepatitis C infections","volume":"33","author":"Venkatraman","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.chembiol.2006.05.004","article-title":"Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications","volume":"13","author":"Lee","year":"2006","journal-title":"Chem. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/ja909996p","article-title":"Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors","volume":"132","author":"Culhane","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/abio.1997.2391","article-title":"A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: Applications in detecting the activity of phagocyte NADPH oxidase and other oxidases","volume":"253","author":"Zhou","year":"1997","journal-title":"Anal. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/cb500018s","article-title":"A selective phenelzine analogue inhibitor of histone demethylase LSD1","volume":"9","author":"Prusevich","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/10799893.2015.1049360","article-title":"Insight into the binding mode of a novel LSD1 inhibitor by molecular docking and molecular dynamics simulations","volume":"35","author":"Zhang","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","volume":"443","author":"Morris","year":"2008","journal-title":"Mol. Model. Proteins"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.18231\/j.ijcaap.2022.003","article-title":"Basics, types and applications of molecular docking: A review","volume":"7","author":"Raval","year":"2022","journal-title":"IP Int. J. Compr. Adv. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1080\/07391102.2019.1621210","article-title":"Computational investigation on effect of mutations in PCNA resulting in structural perturbations and inhibition of mismatch repair pathway","volume":"38","author":"Bhardwaj","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/jcb.25555","article-title":"Mutational analysis on membrane associated transporter protein (MATP) and their structural consequences in oculocutaeous albinism type 4 (OCA4)\u2014A molecular dynamics approach","volume":"117","author":"Kamaraj","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Salo-Ahen, O.M., Alanko, I., Bhadane, R., Bonvin, A.M., Honorato, R.V., Hossain, S., Juffer, A.H., Kabedev, A., Lahtela-Kakkonen, M., and Larsen, A.S. (2020). Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes, 9.","DOI":"10.3390\/pr9010071"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/07391102.2012.759885","article-title":"Drug resistance mechanism of PncA in Mycobacterium tuberculosis","volume":"32","author":"Rajendran","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2007.11.066","article-title":"Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A","volume":"366","author":"Mimasu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9750","DOI":"10.1073\/pnas.1633804100","article-title":"Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures","volume":"100","author":"Binda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1021\/bi100299r","article-title":"Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1\/KDM1","volume":"49","author":"Mimasu","year":"2010","journal-title":"Biochemistry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejmech.2017.09.038","article-title":"Design and synthesis of tranylcypromine derivatives as novel LSD1\/HDACs dual inhibitors for cancer treatment","volume":"140","author":"Duan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1021\/acs.jmedchem.1c02156","article-title":"Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_53","unstructured":"Dhanak, D. (2013, January 6\u201310). Drugging the cancer epigenome. Proceedings of the 104th Annual Meeting of the American Association for Cancer Research, Washington, DC, USA."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1039\/c3md00226h","article-title":"Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments","volume":"4","author":"Hitchin","year":"2013","journal-title":"MedChemComm"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/acs.jmedchem.5b01361","article-title":"3-(Piperidin-4-ylmethoxy) pyridine containing compounds are potent inhibitors of lysine specific demethylase 1","volume":"59","author":"Wu","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1080\/07391102.2018.1518158","article-title":"Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations","volume":"37","author":"Wang","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/cas.14532","article-title":"5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes","volume":"111","author":"Blondy","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"ii45","DOI":"10.1093\/jac\/dkab177","article-title":"Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Versporten","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3389\/fonc.2020.01129","article-title":"Use of allopurinol to mitigate 6-mercaptopurine associated gastrointestinal toxicity in acute lymphoblastic leukemia","volume":"10","author":"Conneely","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14756366.2016.1247054","article-title":"Novel 1-(2-pyrimidin-2-yl) piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors","volume":"32","author":"Kaya","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/jm301686s","article-title":"Synthesis of (E)-8-(3-chlorostyryl) caffeine analogues leading to 9-deazaxanthine derivatives as dual A2A antagonists\/MAO-B inhibitors","volume":"56","author":"Rivara","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1021\/jm070728r","article-title":"Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine-and 1,2,4-triazine-containing tricyclic derivatives","volume":"50","author":"Carotti","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1021\/acs.jmedchem.5b00037","article-title":"Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents","volume":"58","author":"Ma","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/j.bmcl.2017.05.065","article-title":"3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors","volume":"27","author":"Ding","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bioorg.2018.11.018","article-title":"Identification of osimertinib (AZD9291) as a lysine specific demethylase 1 inhibitor","volume":"84","author":"Li","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wang, X., Zhang, C., Zhang, X., Wang, J., Zhao, L., Zhao, D., and Cheng, M. (2022). Design, synthesis and biological evaluation of 2-aminopyrimidine-based LSD1 inhibitors. Bioorg. Chem., 121.","DOI":"10.1016\/j.bioorg.2022.105699"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"14522","DOI":"10.1021\/acs.jmedchem.0c00978","article-title":"Discovery of CC-90011: A potent and selective reversible inhibitor of lysine specific demethylase 1 (LSD1)","volume":"63","author":"Kanouni","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_68","first-page":"84","article-title":"Progress in anti-tumor agents: Triazoles","volume":"23","author":"Mi","year":"2008","journal-title":"Arch. Pharm."},{"key":"ref_69","first-page":"1429","article-title":"Recent advances in the researches of triazole compounds as medicinal drugs","volume":"41","author":"Yan","year":"2011","journal-title":"Sci. Sin. Chim."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2012.12.046","article-title":"Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents","volume":"62","author":"Duan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1021\/jm401002r","article-title":"Triazole\u2013dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration","volume":"56","author":"Zheng","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"29833","DOI":"10.1039\/C8CP03090A","article-title":"Probing the binding mode and unbinding mechanism of LSD1 inhibitors by combined computational methods","volume":"20","author":"Sun","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1080\/07391102.2018.1538903","article-title":"Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening","volume":"37","author":"Sun","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/acsmedchemlett.6b00423","article-title":"Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine derivatives as novel LSD1 inhibitors","volume":"8","author":"Li","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.apsb.2019.01.001","article-title":"Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1\/KDM1A)","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"111989","DOI":"10.1016\/j.ejmech.2019.111989","article-title":"[1,2,3]Triazolo[4,5-d]pyrimidine derivatives incorporating (thio) urea moiety as a novel scaffold for LSD1 inhibitors","volume":"187","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.apsb.2020.02.006","article-title":"Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1, 2, 3-triazole moiety as potent FAD-based LSD1 inhibitors","volume":"10","author":"Ma","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1039\/C4MD00283K","article-title":"3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors","volume":"5","author":"Kutz","year":"2014","journal-title":"MedChemComm"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Alsehli, M., Aljuhani, A., Ihmaid, S.K., El-Messery, S.M., Othman, D.I., El-Sayed, A.-A.A., Ahmed, H.E., Rezki, N., and Aouad, M.R. (2022). Design and Synthesis of Benzene Homologues Tethered with 1,2,4-Triazole and 1,3,4-Thiadiazole Motifs Revealing Dual MCF-7\/HepG2 Cytotoxic Activity with Prominent Selectivity via Histone Demethylase LSD1 Inhibitory Effect. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158796"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4155\/fmc.15.68","article-title":"Hologram quantitative structure\u2013activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors","volume":"7","author":"Maltarollo","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"107440","DOI":"10.1016\/j.jmgm.2019.107440","article-title":"Amino-carboxamide benzothiazoles as potential LSD1 hit inhibitors. Part I: Computational fragment-based drug design","volume":"93","author":"Alnabulsi","year":"2019","journal-title":"J. Mol. Graph. Model."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acs.jmedchem.0c02176","article-title":"Reversible lysine specific demethylase 1 (LSD1) inhibitors: A promising wrench to impair LSD1","volume":"64","author":"Dai","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1016\/j.bmcl.2017.05.018","article-title":"Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1","volume":"27","author":"Mould","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.molstruc.2018.11.019","article-title":"In silico evaluation of 5-hydroxypyrazoles as LSD1 inhibitors based on molecular docking derived descriptors","volume":"1179","author":"Seraj","year":"2019","journal-title":"J. Mol. Struct."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1021\/acs.jmedchem.6b01018","article-title":"Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A\/LSD1. Part 1: High-throughput screening and preliminary exploration","volume":"60","author":"Sartori","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/acs.jmedchem.6b01019","article-title":"Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A\/LSD1. Part 2: Structure-based drug design and structure\u2013activity relationship","volume":"60","author":"Vianello","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1039\/C9RA10085G","article-title":"3D-QSAR, molecular docking, and molecular dynamics simulation study of thieno[3,2-b]pyrrole-5-carboxamide derivatives as LSD1 inhibitors","volume":"10","author":"Xu","year":"2020","journal-title":"RSC Adv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/07391102.2020.1726819","article-title":"Molecular docking, 3D-QSAR, and molecular dynamics simulations of thieno[3,2-b]pyrrole derivatives against anticancer targets of KDM1A\/LSD1","volume":"39","author":"Zhang","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2174\/138955709788452649","article-title":"From nature to drug discovery: The indole scaffold as a \u2018privileged structure\u2019","volume":"9","author":"Barreiro","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3998\/ark.5550190.0011.b15","article-title":"Synthesis of some new indole derivatives containing pyrazoles with potential antitumor activity","volume":"11","author":"Farghaly","year":"2010","journal-title":"Arkivoc"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Gribble, G.W. (2010). Heterocyclic Scaffolds II: Reactions and Applications of Indoles, Springer Science & Business Media.","DOI":"10.1007\/978-3-642-15733-2"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"33756","DOI":"10.18632\/oncotarget.16808","article-title":"Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bioorg.2018.02.016","article-title":"Design, synthesis and biological activity of 4-(4-benzyloxy) phenoxypiperidines as selective and reversible LSD1 inhibitors","volume":"78","author":"Xi","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejmech.2019.04.065","article-title":"Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2 (3H)-one as irreversible LSD1 inhibitors","volume":"175","author":"Liu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"114523","DOI":"10.1016\/j.ejmech.2022.114523","article-title":"Identification of novel indole derivatives as highly potent and efficacious LSD1 inhibitors","volume":"239","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"112243","DOI":"10.1016\/j.ejmech.2020.112243","article-title":"Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors","volume":"194","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2100102","DOI":"10.1002\/ardp.202100102","article-title":"Design, synthesis, and biological evaluation of 5-aminotetrahydroquinoline-based LSD1 inhibitors acting on Asp375","volume":"354","author":"Yan","year":"2021","journal-title":"Arch. Pharm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1039\/c3ob40217g","article-title":"Synthesis and evaluation of 3-amino\/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties","volume":"11","author":"Dulla","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"ref_100","first-page":"781","article-title":"Sanguinarine, identified as a natural alkaloid LSD1 inhibitor, suppresses lung cancer cell growth and migration","volume":"25","author":"Qin","year":"2022","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Li, Z.R., Suo, F.Z., Guo, Y.J., Cheng, H.F., Niu, S.H., Shen, D.D., Zhao, L.J., Liu, Z.Z., Maa, M., and Yu, B. (2020). Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation. Bioorg. Chem., 97.","DOI":"10.1016\/j.bioorg.2020.103648"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4155\/fmc-2021-0105","article-title":"Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitors","volume":"13","author":"Xu","year":"2021","journal-title":"Future Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejphar.2012.05.039","article-title":"The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages","volume":"689","author":"Niu","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Rigacci, S., and Stefani, M. (2016). Nutraceutical properties of olive oil polyphenols. An itinerary from cultured cells through animal models to humans. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060843"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Reboredo-Rodr\u00edguez, P., Varela-L\u00f3pez, A., Forbes-Hern\u00e1ndez, T.Y., Gasparrini, M., Afrin, S., Cianciosi, D., Zhang, J., Manna, P.P., Bompadre, S., and Quiles, J.L. (2018). Phenolic compounds isolated from olive oil as nutraceutical tools for the prevention and management of cancer and cardiovascular diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082305"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2019.01.045","article-title":"Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies","volume":"142","author":"Celano","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2018.00116","article-title":"Effects of oleacein on high-fat diet-dependent steatosis, weight gain, and insulin resistance in mice","volume":"9","author":"Lombardo","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1800456","DOI":"10.1002\/mnfr.201800456","article-title":"Cardiovascular benefits of phenol-enriched virgin olive oils: New insights from the virgin olive oil and HDL functionality (VOHF) study","volume":"62","author":"Pedret","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Angeloni, C., Malaguti, M., Barbalace, M.C., and Hrelia, S. (2017). Bioactivity of olive oil phenols in neuroprotection. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112230"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Cuy\u00e0s, E., Gumuzio, J., Lozano-S\u00e1nchez, J., Carreras, D., Verdura, S., Llorach-Par\u00e9s, L., Sanchez-Martinez, M., Selga, E., P\u00e9rez, G.J., and Scornik, F.S. (2019). Extra virgin olive oil contains a phenolic inhibitor of the histone demethylase LSD1\/KDM1A. Nutrients, 11.","DOI":"10.3390\/nu11071656"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"107575","DOI":"10.1016\/j.jmgm.2020.107575","article-title":"Chromatin modification by olive phenolics: In silico molecular docking studies utilising the phenolic groups categorised in the OliveNet\u2122 database against lysine specific demethylase enzymes","volume":"97","author":"Pitsillou","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"ref_112","first-page":"56","article-title":"Natural Polyphenols Inhibit Lysine-Specific Demethylase-1 in vitro","volume":"1","author":"Abdulla","year":"2013","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejmech.2016.11.035","article-title":"Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation","volume":"126","author":"Duan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1016\/j.bmc.2018.10.037","article-title":"Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy","volume":"26","author":"Duan","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","article-title":"Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins","volume":"110","author":"Cramer","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/qsar.19880070105","article-title":"Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies","volume":"7","author":"Cramer","year":"1988","journal-title":"Quant. Struct. Relatsh."},{"key":"ref_117","unstructured":"Klebe, G. (1998). 3D QSAR in Drug Design, Springer."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ejmech.2008.07.019","article-title":"3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods","volume":"44","author":"Zhu","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Xu, Y., He, Z., Yang, M., Gao, Y., Jin, L., Wang, M., Zheng, Y., Lu, X., Zhang, S., and Wang, C. (2019). Investigating the binding mode of reversible LSD1 inhibitors derived from stilbene derivatives by 3D-QSAR, molecular docking, and molecular dynamics simulation. Molecules, 24.","DOI":"10.3390\/molecules24244479"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/14786419.2010.495070","article-title":"Protective effects of baicalin and quercetin on an iron-overloaded mouse: Comparison of liver, kidney and heart tissues","volume":"25","author":"Zhang","year":"2011","journal-title":"Nat. Prod. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jep.2013.08.020","article-title":"Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury","volume":"150","author":"Xu","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bioorg.2016.10.004","article-title":"Baicalin, a natural LSD1 inhibitor","volume":"69","author":"Zheng","year":"2016","journal-title":"Bioorg. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.aca.2018.01.014","article-title":"Bioactivity-guided cut countercurrent chromatography for isolation of lysine-specific demethylase 1 inhibitors from Scutellaria baicalensis Georgi","volume":"1016","author":"Han","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bmc.2018.12.013","article-title":"Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro","volume":"27","author":"Xu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/08927022.2017.1380802","article-title":"Screening potential inhibitors for cancer target LSD1 from natural products by steered molecular dynamics","volume":"44","author":"Thai","year":"2018","journal-title":"Mol. Simul."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Chen, C.Y.-C. (2011). TCM Database@ Taiwan: The world\u2019s largest traditional Chinese medicine database for drug screening in silico. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0015939"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1021\/jm100217a","article-title":"(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators","volume":"53","author":"Sharma","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bmc.2015.01.049","article-title":"Structure\u2013activity study for (bis) ureidopropyl-and (bis) thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures","volume":"23","author":"Nowotarski","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"114042","DOI":"10.1016\/j.ejmech.2021.114042","article-title":"Annual review of lysine-specific demethylase 1 (LSD1\/KDM1A) inhibitors in 2021","volume":"228","author":"Song","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Ma, Y., Cao, H., Yan, L., Gu, Y., Ren, X., Jiao, X., Wan, S., and Shao, F. (2021). Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. Bioorg. Chem., 108.","DOI":"10.1016\/j.bioorg.2020.104561"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4155\/fmc-2020-0323","article-title":"Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma","volume":"13","author":"Ma","year":"2021","journal-title":"Future Med. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1021\/acs.jmedchem.7b00462","article-title":"Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1","volume":"60","author":"Mould","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.molstruc.2018.08.029","article-title":"Investigating the binding mechanism of (4-Cyanophenyl)glycine derivatives as reversible LSD1 by 3D-QSAR, molecular docking and molecular dynamics simulations","volume":"1175","author":"Wang","year":"2019","journal-title":"J. Mol. Struct."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1021\/jm400792m","article-title":"Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity","volume":"56","author":"Schmitt","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cbpa.2007.07.014","article-title":"LSD1 and the chemistry of histone demethylation","volume":"11","author":"Culhane","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0968-0004(99)01533-9","article-title":"Flavoenzymes: Diverse catalysts with recurrent features","volume":"25","author":"Fraaije","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1021\/jm400870h","article-title":"High-throughput virtual screening identifies novel N\u2032-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors","volume":"56","author":"Sorna","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1016\/j.bmcl.2015.06.054","article-title":"Synthesis and biological evaluation of novel (E)-N\u2032-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors","volume":"26","author":"Zhou","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Zhou, J., Wu, S., Lee, B.G., Chen, T., He, Z., Lei, Y., Tang, B., and Hirst, J.D. (2021). Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1. Molecules, 26.","DOI":"10.3390\/molecules26247492"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Wang, D., Wu, Z., Shen, C., Bao, L., Luo, H., Wang, Z., Yao, H., Kong, D.-X., Luo, C., and Hou, T. (2023). Learning with uncertainty to accelerate the discovery of histone lysine-specific demethylase 1A (KDM1A\/LSD1) inhibitors. Brief. Bioinform., 24.","DOI":"10.1093\/bib\/bbac592"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/1538-7445.AM2021-1461","article-title":"PHI-101, a potent and novel inhibitor of CHK2 in ovarian and breast cancer cells","volume":"81","author":"Han","year":"2021","journal-title":"Cancer Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/2\/550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:47:28Z","timestamp":1760104048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/2\/550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":142,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["molecules29020550"],"URL":"https:\/\/doi.org\/10.3390\/molecules29020550","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}